Research Article
CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
Table 1
Correlations between CSRP1 expression and COAD patients’ characteristics.
| Variables | Cases (n = 167) | CSRP1 protein level | value | Low (n = 90) | High (n = 77) |
| Age (years) | ≤65 | 80 | 43 | 37 | 0.972 | >65 | 87 | 47 | 40 | | Sex | Female | 86 | 52 | 34 | 0.079 | Male | 81 | 38 | 43 | | Tumor location | Ascending colon | 43 | 24 | 19 | 0.227 | Transverse colon | 30 | 20 | 10 | | Descending-sigmoid colon | 94 | 46 | 48 | | Tumor size (cm) | ≤3.5 | 86 | 56 | 30 | | >3.5 | 81 | 34 | 47 | | T stage | T1 | 33 | 24 | 9 | 0.058 | T2 | 21 | 8 | 13 | | T3 | 91 | 48 | 43 | | T4 | 22 | 10 | 12 | | Lymph node status | Negative | 96 | 58 | 38 | | Positive | 71 | 32 | 39 | | Chemotherapy | No or unknown | 109 | 61 | 48 | 0.462 | Accepted | 58 | 29 | 29 | |
|
|